Pharmacopsychiatry Journal
banner
pharmacopsychiatry.bsky.social
Pharmacopsychiatry Journal
@pharmacopsychiatry.bsky.social
Pharmacopsychiatry is a leading international Thieme journal focused on the field of psychotropic drugs. The journal is the official publishing organ of the AGNP.

https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000054
This systematic #review offers a more comprehensive overview of the safety and tolerability profile of an emerging treatment for adults with schizophrenia:

🔗 www.thieme-connect.de/products/ejo...
November 14, 2025 at 4:16 PM
A study in our latest issue seeks to clarify how low-grade inflammation influences the antidepressant and antisuicidal effects of low-dose ketamine infusion in patients with treatment-resistant depression. Find out more at the link below!

📖 www.thieme-connect.de/products/ejo...
November 3, 2025 at 10:25 AM
#Celebrating a #milestone today - we reached our 1000 follower mark this week!

Thank you for your engagement with our channel and we look forward to sharing much more with you soon!
August 29, 2025 at 9:09 AM
🧠 In this study, the #feasibility of implementing #Measurement-BasedCare was assessed for #patients with #MajorDepressiveDisorder seen in a large #outpatient #psychiatry #clinic.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
July 18, 2025 at 1:21 PM
💊 This systematic review investigates the instruments measuring #medicationliteracy (ML) in #psychiatric #patients and their #caregivers.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
July 4, 2025 at 3:46 PM
🐁 Three #NOX #isotypes are expressed mainly in the #brain: NOX2, NOX3 and NOX4, this study explored the expression and #cellular sources of these NOX #isoforms was investigated in the context of stress-induced #depression.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
June 20, 2025 at 3:16 PM
🧠 Given the complicated procedure of the dex/CRH-test, this study aimed to develop a #genetic variants-based alternative approach to predict the outcome of the dex/CRH-test in acute #depression.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
June 6, 2025 at 9:17 AM
🧠 This narrative #review discusses how the safe and effective use of #clinicalAI #prediction tools requires recognition of the importance of human intelligence.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
May 30, 2025 at 2:01 PM
‼️ 📢 Announcing Pharmacopsychiatry's Most Innovative Paper of 2024 📢 ‼️

Our wonderful Pharmacopsychiatry Editors and Advisory Board members have voted, and we are thrilled to announce that the winner of the first ever Most Innovative Paper award is... 🥁

💻 www.thieme-connect.com/products/ejo...
May 19, 2025 at 11:37 AM
💊 This study aims to determine the prevalence of Z-drug #prescribing among #Medicare Part D patients and identify state or specialty-dependent prescribing differences, along with determining prescribing patterns of Z-drugs to Medicare patients.

💻 www.thieme-connect.com/products/ejo...
May 16, 2025 at 3:26 PM
💊 Dose-related reference ranges can be used in #therapeutic #drug monitoring to monitor #pharmacotherapy.

💊 The serum concentrations of patients treated with #cariprazine regularly deviated from this dose-related reference range.

💻 www.thieme-connect.com/products/ejo...
May 9, 2025 at 1:48 PM
💊 Most research fails to distinguish between acquired and innate #resistance, with limited data on treatment resistance (TR) in first episode #psychosis (FEP).

💊 To further understand this, data of FEP patients with and without TR were compared.

💻 www.thieme-connect.com/products/ejo...
April 25, 2025 at 1:54 PM
💊 Currently available systematic reviews on the #pharmacological treatment of #AutismSpectrumDisorder (ASD) do not encompass all the evidence, as they exclude #guidelines issued by national or local authorities that are not indexed in search engines.

💻 www.thieme-connect.com/products/ejo...
April 11, 2025 at 1:23 PM
🍃 #Cannabidiol (CBD), a naturally occurring #cannabinoid, has been investigated in several #psychiatric conditions.

🍃 This review comprises a comprehensive literature search to identify clinical studies on the effects of #CBD in psychiatric conditions.

💻 www.thieme-connect.com/products/ejo...
April 4, 2025 at 12:19 PM
💊 Several randomized controlled trials (RCTs) have compared the effectiveness, efficacy, and safety of #antipsychotic #monotherapy (APM) versus placebo in patients with major depressive disorder, this #review conducts a meta-analysis to examine this topic.

💻 www.thieme-connect.com/products/ejo...
March 28, 2025 at 2:06 PM
💉 One of the first Reviews to study submaximal #prolactin responses to #Thyrotropin-releasing #hormone (TRH) and correlate #mini-TRH test results with key #psychotic symptoms, including memory dysfunction in inpatients hospitalized for acute #psychosis

💻 www.thieme-connect.com/products/ejo...
March 21, 2025 at 3:30 PM
💊 This retrospective cohort study was the first to investigate whether there was a difference in treatment discontinuation for #Japanese adults with #bipolar #disorder between the #lurasidone and #quetiapine treatment groups.

💻Read the article on: www.thieme-connect.com/products/ejo...
March 14, 2025 at 9:29 AM
Celebrating International Women's Day!

This #InternationalWomensDay, all of us at Pharmacopsychiatry celebrate the pivotal contributions of all #WomenInScience. We are committed to equity in research and innovation. To our editors, our authors, our readers, and our community - we appreciate you 💖
March 8, 2025 at 9:15 AM
💊 Partial response to #pharmacotherapy is common in major depressive disorder and many patients require alternative pharmacotherapy or augmentation, including adjunctive L-methylfolate, which is rarely included in major clinical practice guidelines.

💻 www.thieme-connect.com/products/ejo...
March 7, 2025 at 11:55 AM
📢 A fascinating #OpenAccess read for your #weekend!

💊 #Pharmacoepidemiological data suggest that #lithium prescriptions for #bipolar disorder are gradually decreasing, with less attention having been paid to other indications.

💻 www.thieme-connect.de/products/ejo...
February 28, 2025 at 1:03 PM
A great #OpenAccess #Review by Kirsten R. Müller-Vahl

🌿 This Review summarizes current research into #cannabis based #medicines and their potential for use in the #treatment of #psychiatric disorders.

📖 Read the full article online to find out more:
lnkd.in/gV7QvfRD
February 21, 2025 at 10:38 AM
📢 An #OpenAccess read for your #weekend!

💊 This study examines the treatment effects of Escitalopram and pharmacokinetic influences on blood levels, and highlights the potential of therapeutic drug monitoring to support decisions on dosing.

💻 www.thieme-connect.de/products/ejo...

#MentalHealth
February 14, 2025 at 12:38 PM
Celebrating #InternationalDayofWomenandGirlsInScience!

Science thrives on #diversity and collaboration and today we celebrate the brilliant female minds behind innovations in #pharmacological #psychiatry #research.

#WomenInScience #GirlsInSTEM #WomenInSTEM #ScienceForAll #InspireTheFuture
February 11, 2025 at 3:45 PM
📢 A great Monday read:
The latest article by F. Holsboer and M. Ising (MPI of Psychiatry)

Find out all about their #precision #medicine approach looking for the next major innovation in the #pharmacotherapy of #depression:

www.thieme-connect.com/products/ejo...
February 10, 2025 at 2:05 PM
📢 We're now on Bluesky!

🧠 Pharmacopsychiatry is a Q1 Thieme journal that provides #psychiatrists, #neuroscientists and #clinicians with key clinical insights and describes new avenues of #research and treatment of #PsychiatricDisorders.

💻 Check out our website for more details:
lnkd.in/dKzmxptd
January 29, 2025 at 9:37 AM